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To the Editor,
High risk human papilloma viruses (HPV) have been 
found in head and neck squamous cell carcinomas 
(HNSCC), particularly in oropharyngeal carcinomas 
(1). Nevertheless, there are some controversial aspects 
regarding this issue (2) such as whether the HPV infec-
tion is a temporary or a persistent oral infection in these 
patients.
Recently, Chuang et al. (3) have associated the presence 
of HPV-16 DNA in surveillance salivary rinses with a 
significant risk for recurrence in HNSCC.
We hypothesized that the improved prognosis of many 
patients with HPV-related oropharyngeal carcinoma is 
due to the temporary nature of the infection, and there-
fore in the absence of lesions no HPV genomic DNA is 
detected in oral smears.
We have analyzed a longitudinal cohort of 47 patients 
who had been treated for a previous oral squamous cell 
carcinoma (OSCC) without any precancerous or cancer-
ous oral lesion when the oral smear was collected. The 
group was composed of 29 men and 18 women with a 
mean age of 62.02 years (45-87 years). Primary OSCC 
sites were tongue (44.6%), floor of the mouth (31.9%), 
oropharynx (17%), gingiva (12.7%) and buccal muco-
sa (8.5%). Tumours were classified as T1 (53.3%), T2 
(37.7%), T3 (2.2%) and T4 (6.6%).
A cytological brush (CytobrushTM) was vigorously 
swabbed over the oral cavity. Cytological samples were 
centrifuged at 1500 rpm for 15 minutes and washed 
with phosphate-buffered saline (PBS) to obtain the 
cellular pellet. DNA was extracted following the clas-
sical proteinase-K, phenol/chloroform method and pre-
cipitated with ethanol. The detection of HPV genomic 
DNA was performed using the Papitype kit (Progenie-
Molecular S.L, Valencia. Spain). In brief, a polymerase-
chain reaction (PCR) targeting the L1 region of the viral 
genome, harbouring an internal control to avoid false 
negatives, was carried out. Subsequently, and in HPV+ 
samples, typing was performed using a restriction frag-
ment length polymorphism (RFLP).
To our surprise, no HPV genomic DNA was detected 
in any of the samples. These results agree with other 
published data (4, 5) which indicate that the HPV infec-
tion, when present in oral cancer patients, is temporary 
and probably related with the presence of a malignant or 
premalignant lesion.
Conscious of the limitations of our study, we think, as 
other authors (3), that the presence of HPV genomic 
DNA in oral smears may be used as a biomarker in 
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OSCC patients. Additionally, we would like to address 
that the use of oral smears to detect HPV genomic DNA 
is an easy and harmless methodology (6, 7).
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